Quarter report 2/2025 on the location of the chemical-pharmaceutical

Industry / sensitive setback in the chemical business

Frankfurt/Main (ots) –

– Production: strong setback

– producer prices under pressure

– Total sales: weak business at home and abroad

– Outlook: Recovery postponed again

The second quarter of 2025 was for German chemical and Pharmaceutical industry

Overall disappointing. Production, sales and prices went – partly

clearly – back. The hoped -for trend reversal failed to materialize in the domestic business. The

Lack of order even tightened. Many customers from industry throttled

their production and withdrew with chemical orders. The

Chemistry and pharmaceutical business also declined. The decline

However, it was foreseeable here: At the beginning of the year, the important US business occurred

Preduction effects. The exports were temporarily anticipated

Reduced up.

No short -term improvement in sight

How difficult the current situation in the industry is shows in the

Capacity utilization. She collapsed vigorously in the second quarter and only reached

still 71.7 percent – the lowest value since 1991. This remained the utilization

Far below the profitability threshold. An improvement is not in short notice

View. The business expectations have definitely clouded.

VCI general manager Wolfgang Große Entrup commented: “The second quarter

Was another endurance test for the chemistry. Weak demand, falling sales

And a production far below the pre -crisis level – that’s what reality sees at the moment

in our industry and also in large parts of German industry.

Geopolitical crises and political zigzag ignite in the economy. The

Uncertainty in chemical and pharmaceutical companies is huge and paralyzes the business.

The Chancellor’s fire brigade operations on the international floor were correct and

important. In the second 100 days, the government must have the promised

Start spectacular catch -up. Together in the hand and

Deproses the huge bureaucracy and the structural deficits at the location.

Now only acts counts – courageous, fast, determined. “

The numbers at a glance:

– Despite the setback, the VCI sticks to its forecast: the production of the

Chemical and pharmaceutical industry stagnates in 2025. For chemistry

expected a decline of 2 percent. In the case of declining prices, the

Total turnover in the industry then decreased by 1 percent to 221 billion euros.

Neither in Germany nor in abroad is currently being seen

Trend reversal.

– Production fell in the second quarter of 2025 compared to the previous quarter

strong by 3.8 percent. It was 3.1 percent lower than one year

before. The capacity utilization collapsed to 71.7 percent.

– The producer prices were increasingly under pressure. Compared to the previous quarter

the prices of the industry fell by 0.6 percent. So they were 0.2 percent

cheaper than a year earlier.

– The total turnover of the chemical and pharmaceutical industry fell compared to

5.2 percent before quarter. With a value of 52.2 billion euros, it was 2.7

Percent lower than 12 months earlier.

All documents here: https://www.vci.de

The VCI and its specialist associations represent the interests of around 2,300

Companies from the chemical-pharmaceutical industry and chemicals

Economic branches towards politics, authorities, other areas of the economy,

science and the media. In 2024 the member companies of the VCI

Around 240 billion euros and employed over 560,000 employees

Employees.

Press contact:

VCI press office:

Telephone: 069 2556-1496

Email: mailto: [email protected]

The VCI on X and LinkedIn

Further material: http://presseportal.de/pm/12523/6109718

OTS: Association of Chemical Industry (VCI)

ttn-28